21
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

The Discovery and Profile of FluconazoleFootnote

Pages 51-54 | Published online: 14 Jul 2016

References

  • Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immune-compromised host. Am J Med 1981; 71: 363–370.
  • Richardson K, Brammer KW, Marriott MS, Troke PF. Activity of UK-49,858, a bistriazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother 1985; 27: 832–835.
  • Brammer KW, Tarbit MH. A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man, In: R.A. Fromtling (Ed) Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, Barcelona JR. Prous; 1987; p 141.
  • Brammer KW, Lees LJ. Single dose oral fluconazole in the treatment of vulvovaginal candidiasis: An interim analysis of a comparative study vs three-day intravaginal clotrimazole tablets. In: R.A. Fromtling (Ed) Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, Barcelona: J.R. Prous: 1987; 151.
  • Shaw JTB, Tarbit MH, Troke PF. Cytochrome P-450 mediated sterol synthesis and metabolism: Differences in sensitivity to fluconazole and other azoles. In : R.A. Fromtling (Ed.) Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, Barcelona: JR Prous 1987; 125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.